微信扫一扫
实时资讯全掌握
You are the auditor of Nenox, a large public limited pharmaceuticals manufacturer. The audit is complex and high profile and it is particularly important that non-sampling risk is minimised. Which of the following would have no effect on non-sampling risk? A. Review the audit working papers more frequently. B. Produce a detailed planning memorandum. C. Use more experienced staff. D. Increase the number of items selected for detailed testing. |